JP2008543905A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008543905A5 JP2008543905A5 JP2008517437A JP2008517437A JP2008543905A5 JP 2008543905 A5 JP2008543905 A5 JP 2008543905A5 JP 2008517437 A JP2008517437 A JP 2008517437A JP 2008517437 A JP2008517437 A JP 2008517437A JP 2008543905 A5 JP2008543905 A5 JP 2008543905A5
- Authority
- JP
- Japan
- Prior art keywords
- saccharide
- immunogenic composition
- kda
- additional bacterial
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001720 carbohydrates Chemical class 0.000 claims 35
- 239000000203 mixture Substances 0.000 claims 26
- 230000002163 immunogen Effects 0.000 claims 22
- 230000001580 bacterial effect Effects 0.000 claims 12
- 229960005486 vaccine Drugs 0.000 claims 7
- 229960000814 tetanus toxoid Drugs 0.000 claims 6
- 229960003983 diphtheria toxoid Drugs 0.000 claims 4
- 102000014914 Carrier Proteins Human genes 0.000 claims 3
- 108010078791 Carrier Proteins Proteins 0.000 claims 3
- 108010071134 CRM197 (non-toxic variant of diphtheria toxin) Proteins 0.000 claims 2
- 102100037840 Dehydrogenase/reductase SDR family member 2, mitochondrial Human genes 0.000 claims 2
- 101000597577 Gluconacetobacter diazotrophicus (strain ATCC 49037 / DSM 5601 / CCUG 37298 / CIP 103539 / LMG 7603 / PAl5) Outer membrane protein Proteins 0.000 claims 2
- 241000606768 Haemophilus influenzae Species 0.000 claims 2
- 101710183389 Pneumolysin Proteins 0.000 claims 2
- 101710188053 Protein D Proteins 0.000 claims 2
- 101710132893 Resolvase Proteins 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 229940047650 haemophilus influenzae Drugs 0.000 claims 2
- 230000005847 immunogenicity Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 241000588832 Bordetella pertussis Species 0.000 claims 1
- 241000991587 Enterovirus C Species 0.000 claims 1
- 201000009906 Meningitis Diseases 0.000 claims 1
- 241001174901 Neisseria meningitidis alpha275 Species 0.000 claims 1
- 241000588677 Neisseria meningitidis serogroup B Species 0.000 claims 1
- 201000005702 Pertussis Diseases 0.000 claims 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 claims 1
- 241000193998 Streptococcus pneumoniae Species 0.000 claims 1
- 206010043376 Tetanus Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 claims 1
- ILRRQNADMUWWFW-UHFFFAOYSA-K aluminium phosphate Chemical compound O1[Al]2OP1(=O)O2 ILRRQNADMUWWFW-UHFFFAOYSA-K 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 206010013023 diphtheria Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000002672 hepatitis B Diseases 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 230000003053 immunization Effects 0.000 claims 1
- 238000002649 immunization Methods 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims 1
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0513071.1A GB0513071D0 (en) | 2005-06-27 | 2005-06-27 | Immunogenic composition |
| GB0513071.1 | 2005-06-27 | ||
| GBGB0513069.5A GB0513069D0 (en) | 2005-06-27 | 2005-06-27 | Immunogenic composition |
| GB0513069.5 | 2005-06-27 | ||
| GB0515556.9 | 2005-07-28 | ||
| GB0515556A GB0515556D0 (en) | 2005-07-28 | 2005-07-28 | Immunogenic composition |
| GB0524204A GB0524204D0 (en) | 2005-11-28 | 2005-11-28 | Immunogenic composition |
| GB0524204.5 | 2005-11-28 | ||
| GB0526040.1 | 2005-12-21 | ||
| GB0526041A GB0526041D0 (en) | 2005-12-21 | 2005-12-21 | Immunogenic composition |
| GB0526040A GB0526040D0 (en) | 2005-12-21 | 2005-12-21 | Immunogenic composition |
| GB0526041.9 | 2005-12-21 | ||
| PCT/EP2006/006210 WO2007000322A1 (en) | 2005-06-27 | 2006-06-23 | Immunogenic composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008543905A JP2008543905A (ja) | 2008-12-04 |
| JP2008543905A5 true JP2008543905A5 (enExample) | 2009-07-23 |
| JP5037503B2 JP5037503B2 (ja) | 2012-09-26 |
Family
ID=36716943
Family Applications (9)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517440A Pending JP2008543907A (ja) | 2005-06-27 | 2006-06-23 | 免疫原性組成物 |
| JP2008517437A Active JP5037503B2 (ja) | 2005-06-27 | 2006-06-23 | 免疫原性組成物 |
| JP2008517441A Active JP5297800B2 (ja) | 2005-06-27 | 2006-06-23 | 免疫原性組成物 |
| JP2008517436A Active JP5280199B2 (ja) | 2005-06-27 | 2006-06-23 | 免疫原性組成物 |
| JP2008517442A Active JP5731737B2 (ja) | 2005-06-27 | 2006-06-23 | ワクチン作製方法 |
| JP2012241817A Active JP5769688B2 (ja) | 2005-06-27 | 2012-11-01 | 免疫原性組成物 |
| JP2013050333A Active JP5718960B2 (ja) | 2005-06-27 | 2013-03-13 | 免疫原性組成物 |
| JP2013102249A Pending JP2013209395A (ja) | 2005-06-27 | 2013-05-14 | ワクチン作製方法 |
| JP2015091394A Active JP5965512B2 (ja) | 2005-06-27 | 2015-04-28 | 免疫原性組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517440A Pending JP2008543907A (ja) | 2005-06-27 | 2006-06-23 | 免疫原性組成物 |
Family Applications After (7)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008517441A Active JP5297800B2 (ja) | 2005-06-27 | 2006-06-23 | 免疫原性組成物 |
| JP2008517436A Active JP5280199B2 (ja) | 2005-06-27 | 2006-06-23 | 免疫原性組成物 |
| JP2008517442A Active JP5731737B2 (ja) | 2005-06-27 | 2006-06-23 | ワクチン作製方法 |
| JP2012241817A Active JP5769688B2 (ja) | 2005-06-27 | 2012-11-01 | 免疫原性組成物 |
| JP2013050333A Active JP5718960B2 (ja) | 2005-06-27 | 2013-03-13 | 免疫原性組成物 |
| JP2013102249A Pending JP2013209395A (ja) | 2005-06-27 | 2013-05-14 | ワクチン作製方法 |
| JP2015091394A Active JP5965512B2 (ja) | 2005-06-27 | 2015-04-28 | 免疫原性組成物 |
Country Status (36)
Families Citing this family (104)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2277541A1 (en) * | 2000-06-29 | 2011-01-26 | SmithKline Beecham Biologicals S.A. | Multivalent vaccine composition |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| PT2191844E (pt) | 2003-01-30 | 2014-06-04 | Novartis Ag | Vacinas injetáveis contra múltiplos serogrupos meningocócicos |
| GB0408977D0 (en) * | 2004-04-22 | 2004-05-26 | Chiron Srl | Immunising against meningococcal serogroup Y using proteins |
| GB0505518D0 (en) * | 2005-03-17 | 2005-04-27 | Chiron Srl | Combination vaccines with whole cell pertussis antigen |
| US7955605B2 (en) * | 2005-04-08 | 2011-06-07 | Wyeth Llc | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| WO2007000341A2 (en) | 2005-06-27 | 2007-01-04 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
| AU2012261764B2 (en) * | 2005-09-01 | 2016-09-08 | Novartis Vaccines And Diagnostics Gmbh & Co. Kg | Multiple vaccination including serogroup C meningococcus |
| BRPI0615420A2 (pt) * | 2005-09-01 | 2011-05-17 | Novartis Vaccines & Diagnostic | vacinação múltipla que inclui meningococo do sorogrupo c |
| HUE032903T2 (hu) | 2005-12-22 | 2017-11-28 | Glaxosmithkline Biologicals Sa | Streptococcus pneumoniae kapszulárispoliszacharid-konjugátumok |
| DK2004225T3 (da) * | 2006-03-22 | 2012-08-06 | Novartis Ag | Programmer for vaccination med meningocockonjugater |
| US10828361B2 (en) * | 2006-03-22 | 2020-11-10 | Glaxosmithkline Biologicals Sa | Regimens for immunisation with meningococcal conjugates |
| GB0612854D0 (en) | 2006-06-28 | 2006-08-09 | Novartis Ag | Saccharide analysis |
| WO2008028957A2 (en) | 2006-09-07 | 2008-03-13 | Glaxosmithkline Biologicals S.A. | Vaccine |
| AR064642A1 (es) | 2006-12-22 | 2009-04-15 | Wyeth Corp | Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi |
| GB0700136D0 (en) * | 2007-01-04 | 2007-02-14 | Glaxosmithkline Biolog Sa | Process for manufacturing vaccines |
| GB0700135D0 (en) * | 2007-01-04 | 2007-02-14 | Glaxosmithkline Biolog Sa | Vaccine |
| CN104873965B (zh) * | 2007-06-26 | 2018-09-11 | 葛兰素史密丝克莱恩生物有限公司 | 包含肺炎链球菌荚膜多糖缀合物的疫苗 |
| GB0713880D0 (en) | 2007-07-17 | 2007-08-29 | Novartis Ag | Conjugate purification |
| US20160228500A9 (en) * | 2007-07-23 | 2016-08-11 | Martina Ochs | Immunogenic Polypeptides and Monoclonal Antibodies |
| GB0714963D0 (en) | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| SI2200642T1 (sl) | 2007-10-19 | 2012-06-29 | Novartis Ag | Formulacije meningokoknega cepiva |
| EP2328613A1 (en) * | 2008-08-28 | 2011-06-08 | GlaxoSmithKline Biologicals S.A. | Vaccine |
| PT2349520T (pt) | 2008-10-27 | 2016-08-16 | Glaxosmithkline Biologicals Sa | Método de purificação para hidrato de carbono de estreptococos grupo a |
| GB0822634D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Meningitis vaccines |
| GB0822633D0 (en) | 2008-12-11 | 2009-01-21 | Novartis Ag | Formulation |
| CN102300585A (zh) | 2008-12-17 | 2011-12-28 | 诺华有限公司 | 包含血红蛋白受体的脑膜炎球菌疫苗 |
| BRPI1009829A2 (pt) | 2009-03-24 | 2016-11-16 | Novartis Ag | combinações de proteína de ligação de fator h meningocócico e conjugados de sacarídeos pneumocócicos |
| ES2797504T3 (es) | 2009-03-24 | 2020-12-02 | Glaxosmithkline Biologicals Sa | Proteína de enlace del factor H meningocócico utilizada como adyuvante |
| JP5593626B2 (ja) * | 2009-03-31 | 2014-09-24 | 凸版印刷株式会社 | 計量スプーン |
| CA3154626A1 (en) | 2009-04-14 | 2010-10-21 | Glaxosmithkline Biologicals S.A. | Compositions for immunising against staphylococcus aureus |
| US20120052088A1 (en) * | 2009-04-30 | 2012-03-01 | Coley Pharmaceutical Group, Inc. | Pneumococcal vaccine and uses thereof |
| GB0910046D0 (en) * | 2009-06-10 | 2009-07-22 | Glaxosmithkline Biolog Sa | Novel compositions |
| PL2445522T3 (pl) | 2009-06-22 | 2018-01-31 | Wyeth Llc | Kompozycje immunogenne antygenów Staphylococcus aureus |
| SG177310A1 (en) * | 2009-06-22 | 2012-02-28 | Wyeth Llc | Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions |
| MX2012002723A (es) | 2009-09-02 | 2012-04-11 | Novartis Ag | Composiciones inmunogenicas que incluyen moduladores de la actividad de receptores tipo toll. |
| CA2773637A1 (en) | 2009-09-10 | 2011-03-17 | Novartis Ag | Combination vaccines against respiratory tract diseases |
| SI2493498T1 (sl) | 2009-10-30 | 2017-07-31 | Glaxosmithkline Biologicals Sa | Čiščenje kapsularnih saharidov Staphylococcusa aureusa tipa 5 in tipa 8 |
| GB0919690D0 (en) | 2009-11-10 | 2009-12-23 | Guy S And St Thomas S Nhs Foun | compositions for immunising against staphylococcus aureus |
| JP5781542B2 (ja) | 2009-12-30 | 2015-09-24 | ノバルティス アーゲー | Ｅ．ｃｏｌｉキャリアタンパク質に結合体化した多糖免疫原 |
| TW201136603A (en) * | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| GB201003333D0 (en) | 2010-02-26 | 2010-04-14 | Novartis Ag | Immunogenic proteins and compositions |
| GB201003924D0 (en) * | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| GB201003922D0 (en) * | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Conjugation process |
| GB201005625D0 (en) | 2010-04-01 | 2010-05-19 | Novartis Ag | Immunogenic proteins and compositions |
| WO2011161653A1 (en) | 2010-06-25 | 2011-12-29 | Novartis Ag | Combinations of meningococcal factor h binding proteins |
| SI2608805T2 (sl) | 2010-08-23 | 2025-09-30 | Wyeth Llc | Stabilne formulacije antigenov rLP2086 neisserie meningitidis |
| CN105999275A (zh) | 2010-09-01 | 2016-10-12 | 诺华有限公司 | 免疫增强剂吸附不溶性金属离子 |
| BR112013005329A2 (pt) | 2010-09-10 | 2017-05-02 | Wyeth Llc | variantes não lipidadas de antígenos orf2086 de neisseria meningitidis |
| BR112013005626B1 (pt) | 2010-09-10 | 2022-07-26 | Glaxosmithkline Biologicals Sa | Meningococo, processo para a preparação de uma cepa meningocócica, vesículas de membrana externa, composição farmacêutica imunogênica, e, uso de uma composição |
| WO2012072769A1 (en) | 2010-12-01 | 2012-06-07 | Novartis Ag | Pneumococcal rrgb epitopes and clade combinations |
| ES2681698T3 (es) | 2011-03-02 | 2018-09-14 | Glaxosmithkline Biologicals Sa | Vacunas de combinación con menores dosis de antígeno y/o adyuvante |
| GB201114923D0 (en) | 2011-08-30 | 2011-10-12 | Novartis Ag | Immunogenic proteins and compositions |
| AU2012335208B2 (en) | 2011-11-07 | 2017-08-31 | Glaxosmithkline Biologicals S.A. | Carrier molecule comprising a spr0096 and a spr2021 antigen |
| JP2013112653A (ja) * | 2011-11-30 | 2013-06-10 | Jnc Corp | 新規重合体およびその製造方法 |
| GB201121301D0 (en) | 2011-12-12 | 2012-01-25 | Novartis Ag | Method |
| CA2862247A1 (en) | 2011-12-29 | 2013-07-04 | Novartis Ag | Adjuvanted combinations of meningococcal factor h binding proteins |
| BR112014018815B1 (pt) * | 2012-01-30 | 2022-07-12 | Serum Institute Of India Ltd. | Composição imunogênica compreendendo conjugado proteína-polissacarídeo x de n. meningitidis |
| MX2014008988A (es) | 2012-02-02 | 2014-08-27 | Novartis Ag | Promotores para aumento de expresion de proteinas en meningococo. |
| CN102569723A (zh) * | 2012-02-13 | 2012-07-11 | 华为技术有限公司 | 锂离子电池正极材料及其制备方法、正极及锂离子电池 |
| CN104519910B (zh) | 2012-03-07 | 2017-05-03 | 诺华股份有限公司 | 肺炎链球菌抗原的含佐剂制剂 |
| US20150125486A1 (en) | 2012-03-08 | 2015-05-07 | Novartis Ag | Adjuvanted formulations of pediatric antigens |
| AU2013229432A1 (en) | 2012-03-08 | 2014-10-16 | Novartis Ag | Adjuvanted formulations of booster vaccines |
| MX2018011291A (es) | 2012-03-09 | 2023-01-31 | Pfizer | Composiciones de neisseria meningitidis y metodos de las mismas. |
| SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
| KR102057217B1 (ko) | 2012-06-20 | 2020-01-22 | 에스케이바이오사이언스 주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
| US9526776B2 (en) | 2012-09-06 | 2016-12-27 | Glaxosmithkline Biologicals Sa | Combination vaccines with serogroup B meningococcus and D/T/P |
| ITMI20121597A1 (it) | 2012-09-25 | 2014-03-26 | Beta Pharma S A | Coniugato tra frammento di parete cellulare batterica ed un veicolo mucopolisaccaridico e suoi usi in ambito medico |
| BR112015007126A2 (pt) | 2012-10-02 | 2017-08-08 | Glaxosmithkline Biologicals Sa | composição, método para induzir uma resposta imune, e, uso de uma composição |
| CA2892688A1 (en) | 2012-11-30 | 2014-06-05 | Glaxosmithkline Biologicals Sa | Pseudomonas antigens and antigen combinations |
| KR20140075196A (ko) | 2012-12-11 | 2014-06-19 | 에스케이케미칼주식회사 | 다가 폐렴구균 다당류-단백질 접합체 조성물 |
| WO2014095771A1 (en) | 2012-12-18 | 2014-06-26 | Novartis Ag | Conjugates for protecting against diphtheria and/or tetanus |
| WO2014118305A1 (en) | 2013-02-01 | 2014-08-07 | Novartis Ag | Intradermal delivery of immunological compositions comprising toll-like receptor agonists |
| WO2014136064A2 (en) | 2013-03-08 | 2014-09-12 | Pfizer Inc. | Immunogenic fusion polypeptides |
| MX382165B (es) * | 2013-03-18 | 2025-03-13 | Glaxosmithkline Biologicals Sa | Una vacuna conjugada contra n. meningitidis para usarse en la prevención o tratamiento de enfermedades por n. meningitidis. |
| BR112016004463A2 (pt) | 2013-09-08 | 2017-10-17 | Pfizer | composições de neisseria meningitidis e métodos das mesmas |
| IN2014DE02450A (enExample) | 2013-09-25 | 2015-06-26 | Suzuki Motor Corp | |
| RU2535122C1 (ru) * | 2013-11-06 | 2014-12-10 | Федеральное казенное учреждение здравоохранения "Российский научно-исследовательский противочумный институт "Микроб" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека ("РосНИПЧИ "Микроб") | Способ получения холерогена-анатоксина |
| CA2937186C (en) * | 2014-01-21 | 2022-11-01 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| US11160855B2 (en) | 2014-01-21 | 2021-11-02 | Pfizer Inc. | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof |
| EP2921856B1 (en) | 2014-03-18 | 2016-09-14 | Serum Institute Of India Private Limited | A quantitative assay for 4-pyrrolidinopyridine (4-ppy) in polysaccharide-protein conjugate vaccines |
| WO2015158898A2 (en) * | 2014-04-17 | 2015-10-22 | Medizinische Hochschule Hannover | Means and methods for producing neisseria meningitidis capsular polysaccharides of low dispersity |
| WO2016132294A1 (en) | 2015-02-19 | 2016-08-25 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| CN108367063A (zh) * | 2015-07-21 | 2018-08-03 | 辉瑞公司 | 包含缀合的荚膜糖抗原的免疫原性组合物及其试剂盒和用途 |
| US20170333546A1 (en) * | 2015-12-08 | 2017-11-23 | Jl Medical Corporation | Method for Producing and Vaccine Composition of Neisseria Meningitidis Serogroups A, C, Y, and W-135 Oligosaccharides Conjugated to Glycan-Free Carrier Protein |
| WO2017158480A1 (en) * | 2016-03-15 | 2017-09-21 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Novel polysaccharide-protein conjugates and process to obtain thereof |
| AU2017321863B2 (en) * | 2016-09-02 | 2024-07-11 | Sanofi Pasteur, Inc. | Neisseria meningitidis vaccine |
| EP3506933A2 (en) | 2016-09-02 | 2019-07-10 | GlaxoSmithKline Biologicals SA | Vaccines for neisseria gonorrhoeae |
| EP3639848A3 (en) | 2016-09-13 | 2020-12-16 | Allergan, Inc. | Stabilized non-protein clostridial toxin compositions |
| CN109922828A (zh) * | 2016-10-20 | 2019-06-21 | Km生物医药股份公司 | 使用具有降低了的分子量的PRP的Hib结合疫苗的制造方法 |
| US11951165B2 (en) | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| WO2018126229A2 (en) | 2016-12-30 | 2018-07-05 | Sutrovax, Inc. | Polypeptide-antigen conjugates with non-natural amino acids |
| AU2018215585B2 (en) | 2017-01-31 | 2022-03-17 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| US11524076B2 (en) | 2017-09-07 | 2022-12-13 | Merck Sharp & Dohme Llc | Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates |
| JP7218358B2 (ja) | 2017-09-07 | 2023-02-06 | メルク・シャープ・アンド・ドーム・エルエルシー | 肺炎球菌多糖体および免疫原性多糖体－キャリアタンパク質コンジュゲートでのその使用 |
| US20200353064A1 (en) * | 2018-01-29 | 2020-11-12 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Novel meningococcal vaccine composition and process thereof |
| WO2019198096A1 (en) * | 2018-04-11 | 2019-10-17 | Msd Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Tetravalent meningococcal vaccine composition and process to prepare thereof |
| JOP20200214A1 (ar) | 2019-09-03 | 2021-03-03 | Serum Institute Of India Pvt Ltd | تركيبات مولدة للمناعة ضد الأمراض المعوية وطرق لتحضيرها |
| MX2022003682A (es) | 2019-09-27 | 2022-04-25 | Pfizer | Composiciones de neisseria meningitidis y metodos de las mismas. |
| CA3161857A1 (en) | 2019-11-22 | 2021-05-27 | Glaxosmithkline Biologicals Sa | Dosage and administration of a bacterial saccharide glycoconjugate vaccine |
| JP2023548935A (ja) | 2020-11-13 | 2023-11-21 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 新規担体及びコンジュゲーション法 |
| RU2770877C1 (ru) * | 2021-04-08 | 2022-04-22 | Федеральное бюджетное учреждение науки "Ростовский научно-исследовательский институт микробиологии и паразитологии" | Способ получения антигенной конъюгированной субстанции гемофильного типа b микроба для создания вакцинных препаратов |
| GB202215414D0 (en) | 2022-10-18 | 2022-11-30 | Glaxosmithkline Biologicals Sa | Vaccine |
| WO2025021710A1 (en) | 2023-07-21 | 2025-01-30 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
Family Cites Families (184)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB513069A (en) | 1937-04-24 | 1939-10-03 | Linde Air Prod Co | Improvements in method of and apparatus for the treatment of metallic bodies by oxidising gas |
| GB505518A (en) | 1938-02-03 | 1939-05-12 | Daniel Morgan Skeins | Improvements in or relating to envelopes |
| US4057685A (en) | 1972-02-02 | 1977-11-08 | Abbott Laboratories | Chemically modified endotoxin immunizing agent |
| US4123520A (en) * | 1977-08-01 | 1978-10-31 | Merck & Co., Inc. | Method for preparing high molecular weight meningococcal Group C vaccine |
| DE2748132A1 (de) * | 1977-10-27 | 1979-05-03 | Behringwerke Ag | Stabilisator fuer polysaccharid |
| US4235994A (en) * | 1978-06-26 | 1980-11-25 | Merck & Co., Inc. | High molecular weight meningococcal group C vaccine and method for preparation thereof |
| US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
| EP0027888B1 (en) | 1979-09-21 | 1986-04-16 | Hitachi, Ltd. | Semiconductor switch |
| DE3040825A1 (de) * | 1980-10-30 | 1982-09-09 | Dr. Karl Thomae Gmbh, 7950 Biberach | Neues tridekapeptid, verfahren zu seiner herstellung und verwendung |
| US4673574A (en) | 1981-08-31 | 1987-06-16 | Anderson Porter W | Immunogenic conjugates |
| US4459286A (en) | 1983-01-31 | 1984-07-10 | Merck & Co., Inc. | Coupled H. influenzae type B vaccine |
| HU193083B (en) * | 1984-02-22 | 1987-08-28 | Sandoz Ag | Process for preparing diazepinoindole derivatives further pharmaceutical compositions containing such compounds |
| US4695624A (en) | 1984-05-10 | 1987-09-22 | Merck & Co., Inc. | Covalently-modified polyanionic bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins with bigeneric spacers, and methods of preparing such polysaccharides and conjugates and of confirming covalency |
| US4808700A (en) | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
| US4709017A (en) | 1985-06-07 | 1987-11-24 | President And Fellows Of Harvard College | Modified toxic vaccines |
| IT1187753B (it) | 1985-07-05 | 1987-12-23 | Sclavo Spa | Coniugati glicoproteici ad attivita' immunogenica trivalente |
| DE3526940A1 (de) | 1985-07-27 | 1987-02-12 | Siegfried Fricker | Anker zum einbetonieren in schwere lasten |
| IL78929A0 (en) * | 1985-07-29 | 1986-09-30 | Abbott Lab | Microemulsion compositions for parenteral administration |
| US4727136A (en) | 1985-10-01 | 1988-02-23 | Canadian Patents And Development Ltd. | Modified meningococcal group B polysaccharide for conjugate vaccine |
| US4950740A (en) | 1987-03-17 | 1990-08-21 | Cetus Corporation | Recombinant diphtheria vaccines |
| RU2023448C1 (ru) | 1987-07-30 | 1994-11-30 | Сентро Насьональ Де Биопрепарадос | Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в |
| US5180815A (en) * | 1988-04-13 | 1993-01-19 | Fuji Photo Film Co., Ltd. | Modified protein for carrying hapten |
| WO1989011813A1 (fr) | 1988-05-31 | 1989-12-14 | KÖNIG-HAUG, Beatrice | Systeme de rayonnage |
| DE3841091A1 (de) | 1988-12-07 | 1990-06-13 | Behringwerke Ag | Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung |
| ES2055785T3 (es) | 1989-01-17 | 1994-09-01 | Eniricerche Spa | Peptidos sinteticos y su uso como vehiculos universales para la preparacion de conjugados inmunogenos aptos para el desarrollo de vacunas sinteticas. |
| US5334379A (en) | 1989-07-14 | 1994-08-02 | American Cyanamid Company | Cytokine and hormone carriers for conjugate vaccines |
| IT1237764B (it) | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
| ATE121947T1 (de) | 1989-12-14 | 1995-05-15 | Ca Nat Research Council | Verbessertes meningokokkale polysaccharidkonjugatvakzin. |
| SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| IL98715A0 (en) | 1990-08-13 | 1992-07-15 | American Cyanamid Co | Filamentous hemaglutinin of bodetella pertussis as a carrier molecule for conjugate vaccines |
| US5153312A (en) | 1990-09-28 | 1992-10-06 | American Cyanamid Company | Oligosaccharide conjugate vaccines |
| CA2059693C (en) | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| CA2059692C (en) | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
| GB2264352A (en) | 1992-01-31 | 1993-08-25 | Richards Eng Ltd | Incineration apparatus |
| ES2204900T3 (es) | 1992-02-11 | 2004-05-01 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Estructura inmuinogena de doble vector. |
| IT1262896B (it) | 1992-03-06 | 1996-07-22 | Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini. | |
| WO1993021769A1 (en) * | 1992-05-06 | 1993-11-11 | President And Fellows Of Harvard College | Diphtheria toxin receptor-binding region |
| ATE444079T1 (de) | 1992-05-23 | 2009-10-15 | Glaxosmithkline Biolog Sa | Kombinierte impfstoffe, die hepatitis b oberfläche antigen und andere antigenen enthalten |
| IL102687A (en) | 1992-07-30 | 1997-06-10 | Yeda Res & Dev | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them |
| DK0594950T3 (da) | 1992-10-27 | 1999-09-13 | American Cyanamid Co | Pædiatrisk kombinationsvaccine med forbedret immunogenicitet af hver vaccinekomponent |
| CA2128895C (en) | 1992-12-14 | 1999-04-13 | John M. Crowell | Removable piston bore liner for hydraulically actuated seismic vibrator |
| US5849301A (en) * | 1993-09-22 | 1998-12-15 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Producing immunogenic constructs using soluable carbohydrates activated via organic cyanylating reagents |
| AU678613B2 (en) | 1993-09-22 | 1997-06-05 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
| DE4416166C2 (de) * | 1994-05-06 | 1997-11-20 | Immuno Ag | Stabiles Präparat zur Behandlung von Blutgerinnungsstörungen |
| US5869058A (en) * | 1994-05-25 | 1999-02-09 | Yeda Research And Development Co. Ltd. | Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines |
| US5917017A (en) | 1994-06-08 | 1999-06-29 | President And Fellows Of Harvard College | Diphtheria toxin vaccines bearing a mutated R domain |
| US6455673B1 (en) | 1994-06-08 | 2002-09-24 | President And Fellows Of Harvard College | Multi-mutant diphtheria toxin vaccines |
| GB9422096D0 (en) | 1994-11-02 | 1994-12-21 | Biocine Spa | Combined meningitis vaccine |
| JPH11502820A (ja) | 1995-03-22 | 1999-03-09 | ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン | 有機シアン化試薬により活性化された可溶性炭水化物を使用する免疫原性構築物の製造 |
| DE69615362T3 (de) | 1995-06-07 | 2006-07-20 | Smithkline Beecham Biologicals S.A. | Impfstoff mit einem polysaccharidantigen-trägerprotein-konjugat und einem trägerprotein |
| JP4850987B2 (ja) | 1995-06-23 | 2012-01-11 | グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム | リン酸アルミニウム上に吸着したポリサッカライド結合抗原を含むワクチン組成物 |
| SE9601158D0 (sv) | 1996-03-26 | 1996-03-26 | Stefan Svenson | Method of producing immunogenic products and vaccines |
| DE69718211T2 (de) | 1996-10-23 | 2003-11-13 | Matsushita Electric Industrial Co., Ltd. | Optische Platte |
| AU5194598A (en) | 1996-10-31 | 1998-05-22 | Human Genome Sciences, Inc. | (streptococcus pneumoniae) antigens and vaccines |
| AU1420897A (en) | 1996-12-18 | 1998-07-15 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Conjugate vaccine for (salmonella paratyphi) a |
| US6299881B1 (en) | 1997-03-24 | 2001-10-09 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts |
| FR2763244B1 (fr) | 1997-05-14 | 2003-08-01 | Pasteur Merieux Serums Vacc | Composition vaccinale multivalente a porteur mixte |
| GB9713156D0 (en) | 1997-06-20 | 1997-08-27 | Microbiological Res Authority | Vaccines |
| GB9717953D0 (en) | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
| PT1028750E (pt) | 1997-09-15 | 2006-05-31 | Sanofi Pasteur Msd | Metodo de preparacao de vacinas polivalentes |
| AU9399498A (en) | 1997-09-18 | 1999-04-05 | Trustees Of The University Of Pennsylvania, The | Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery |
| US5965714A (en) * | 1997-10-02 | 1999-10-12 | Connaught Laboratories, Inc. | Method for the covalent attachment of polysaccharides to protein molecules |
| US7018637B2 (en) * | 1998-02-23 | 2006-03-28 | Aventis Pasteur, Inc | Multi-oligosaccharide glycoconjugate bacterial meningitis vaccines |
| CA2264970A1 (en) | 1998-03-10 | 1999-09-10 | American Cyanamid Company | Antigenic conjugates of conserved lipolysaccharides of gram negative bacteria |
| GB9806456D0 (en) | 1998-03-25 | 1998-05-27 | Smithkline Beecham Biolog | Vaccine composition |
| GB9808932D0 (en) | 1998-04-27 | 1998-06-24 | Chiron Spa | Polyepitope carrier protein |
| JP2002513028A (ja) | 1998-04-28 | 2002-05-08 | ガレニカ ファーマシューティカルズ， インコーポレイテッド | ポリサッカリド抗原結合体 |
| CN1263510C (zh) | 1998-08-19 | 2006-07-12 | 巴克斯特健康护理股份有限公司 | 多糖－蛋白质缀合物或寡糖－蛋白质缀合物、其制备方法及其应用 |
| AU1626199A (en) † | 1998-12-04 | 2000-06-26 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | A vi-repa conjugate vaccine for immunization against salmonella typhi |
| ES2322306T3 (es) | 1998-12-21 | 2009-06-18 | Medimmune, Inc. | Proteinas de streptpcpccus pneumoniae y fragmentos inmunogenicos para vacunas. |
| US6146902A (en) | 1998-12-29 | 2000-11-14 | Aventis Pasteur, Inc. | Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions |
| EP1156781B1 (en) | 1999-02-26 | 2005-06-08 | Chiron Corporation | Microemulsions with adsorbed macromolecules and microparticles |
| MY125202A (en) | 1999-03-19 | 2006-07-31 | Smithkline Beecham Biologicals S A | Vaccine |
| WO2000061761A2 (en) | 1999-04-09 | 2000-10-19 | Techlab, Inc. | Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines |
| WO2001000790A1 (en) | 1999-06-25 | 2001-01-04 | American Cyanamid Company | Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria |
| GB9918319D0 (en) | 1999-08-03 | 1999-10-06 | Smithkline Beecham Biolog | Vaccine composition |
| GB9925559D0 (en) | 1999-10-28 | 1999-12-29 | Smithkline Beecham Biolog | Novel method |
| JP4948731B2 (ja) | 1999-12-02 | 2012-06-06 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | 凍結乾燥の際に生物学的分子を安定化するための組成物および方法 |
| FR2806304B1 (fr) * | 2000-03-17 | 2002-05-10 | Aventis Pasteur | Conjugues polysaccharidiques du pneumocoque a usage vaccinal contre le tetanos et la diphterie |
| GB0007432D0 (en) | 2000-03-27 | 2000-05-17 | Microbiological Res Authority | Proteins for use as carriers in conjugate vaccines |
| GB0108364D0 (en) | 2001-04-03 | 2001-05-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| EP2277541A1 (en) | 2000-06-29 | 2011-01-26 | SmithKline Beecham Biologicals S.A. | Multivalent vaccine composition |
| CA2416137C (en) * | 2000-07-27 | 2013-01-29 | Dan Granoff | Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| GB0103170D0 (en) | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
| ES2330083T3 (es) | 2000-10-27 | 2009-12-04 | Novartis Vaccines And Diagnostics S.R.L. | Acidos nucleicos y proteinas de estreptococos de los grupos a y b. |
| EP1355673B1 (en) | 2001-01-23 | 2012-05-30 | Sanofi Pasteur Inc. | Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| GB0107658D0 (en) * | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
| GB0107661D0 (en) * | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| WO2002091998A2 (en) | 2001-05-11 | 2002-11-21 | Aventis Pasteur, Inc. | Novel meningitis conjugate vaccine |
| US6615062B2 (en) | 2001-05-31 | 2003-09-02 | Infraredx, Inc. | Referencing optical catheters |
| GB0115176D0 (en) * | 2001-06-20 | 2001-08-15 | Chiron Spa | Capular polysaccharide solubilisation and combination vaccines |
| GB0118249D0 (en) * | 2001-07-26 | 2001-09-19 | Chiron Spa | Histidine vaccines |
| AR045702A1 (es) * | 2001-10-03 | 2005-11-09 | Chiron Corp | Composiciones de adyuvantes. |
| MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
| CU23031A1 (es) * | 2002-01-24 | 2005-02-23 | Ct Ingenieria Genetica Biotech | Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes |
| IL163988A0 (en) | 2002-03-15 | 2005-12-18 | Wyeth Corp | Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| BR0308768A (pt) * | 2002-03-26 | 2005-02-15 | Chiron Srl | Sacarìdeos modificados possuindo estabilidade melhorada em água |
| GB0210128D0 (en) * | 2002-05-02 | 2002-06-12 | Chiron Spa | Nucleic acids and proteins from streptococcus groups A & B |
| RU2378008C2 (ru) | 2002-05-14 | 2010-01-10 | Новартис Вэксинес Энд Дайэгностикс С.Р.Л. | Комбинированные вакцины против бактериального менингита для введения через слизистую оболочку |
| DE60328481D1 (de) | 2002-05-14 | 2009-09-03 | Novartis Vaccines & Diagnostic | Schleimhautapplizierter impfstoff, der das adjuvanz chitosan und menigokokkenantigene enthält |
| GB0302218D0 (en) * | 2003-01-30 | 2003-03-05 | Chiron Sri | Vaccine formulation & Mucosal delivery |
| GB0211118D0 (en) * | 2002-05-15 | 2002-06-26 | Polonelli Luciano | Vaccines |
| AU2003257003A1 (en) * | 2002-07-30 | 2004-02-16 | Baxter Healthcare S.A. | Chimeric multivalent polysaccharide conjugate vaccines |
| GB0220199D0 (en) * | 2002-08-30 | 2002-10-09 | Univ Utrecht | Mutant protein and refolding method |
| NZ587398A (en) * | 2002-08-02 | 2012-03-30 | Glaxosmithkline Biolog Sa | Neisserial bleb preparations and vaccines comprising them |
| GB0220194D0 (en) * | 2002-08-30 | 2002-10-09 | Chiron Spa | Improved vesicles |
| HUE031886T2 (en) | 2002-10-11 | 2017-08-28 | Glaxosmithkline Biologicals Sa | Polypeptide vaccines for extensive protection against hypervirulent meningococcal lines |
| CN1401328A (zh) | 2002-10-18 | 2003-03-12 | 北京绿竹生物技术有限责任公司 | 流行性脑脊髓膜炎多糖－蛋白结合疫苗 |
| SI1556477T1 (sl) * | 2002-11-01 | 2017-12-29 | Glaxosmithkline Biologicals S.A. | Sušilni postopek |
| GB0227346D0 (en) * | 2002-11-22 | 2002-12-31 | Chiron Spa | 741 |
| CN1168501C (zh) | 2002-12-27 | 2004-09-29 | 北京绿竹生物技术有限责任公司 | 一种多糖-蛋白结合疫苗 |
| PT2191844E (pt) * | 2003-01-30 | 2014-06-04 | Novartis Ag | Vacinas injetáveis contra múltiplos serogrupos meningocócicos |
| CA2518669C (en) * | 2003-03-13 | 2014-07-29 | Glaxosmithkline Biologicals S.A. | Purification process |
| US20060251675A1 (en) | 2003-03-17 | 2006-11-09 | Michael Hagen | Mutant cholera holotoxin as an adjuvant and an antigen carrier protein |
| JP2006528936A (ja) | 2003-05-07 | 2006-12-28 | アヴェンティス パストゥール インコーポレイテッド | 多価髄膜炎菌誘導体化多糖−タンパク質複合体およびワクチン |
| EP1631264B8 (en) | 2003-06-02 | 2017-05-24 | GlaxoSmithKline Biologicals SA | Immunogenic compositions based on microparticles comprising adsorbed toxoid and a polysaccharide-containing antigen |
| GB0313916D0 (en) | 2003-06-16 | 2003-07-23 | Glaxosmithkline Biolog Sa | Vaccine composition |
| BRPI0411875A (pt) * | 2003-06-23 | 2006-08-08 | Sanofi Pasteur Inc | método de imunização contra os sorogrupos a e c de neisseria meningitidis |
| KR101034055B1 (ko) | 2003-07-18 | 2011-05-12 | 엘지이노텍 주식회사 | 발광 다이오드 및 그 제조방법 |
| US8048432B2 (en) * | 2003-08-06 | 2011-11-01 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Polysaccharide-protein conjugate vaccines |
| EP2366403B1 (en) * | 2003-08-06 | 2014-10-08 | The Government of The United States of America, as represented by The Secretary, Department of Health and Human Services | Polysaccharide-protein conjugate vaccines |
| US6995363B2 (en) * | 2003-08-21 | 2006-02-07 | Applera Corporation | Reduction of matrix interference for MALDI mass spectrometry analysis |
| RU2378010C2 (ru) * | 2003-10-02 | 2010-01-10 | Новартис Вэксинес Энд Дайэгностикс С.Р.Л. | Жидкие вакцины для множественных серогрупп менингококков |
| WO2005032584A2 (en) | 2003-10-02 | 2005-04-14 | Glaxosmithkline Biologicals S.A. | Pertussis antigens and use thereof in vaccination |
| CA2550927A1 (en) * | 2003-12-23 | 2005-07-14 | Glaxosmithkline Biologicals S.A. | A gram negative bacterium with reduced lps level in the outer membrane and use thereof for treating gram negative bacterial infection |
| GB0405787D0 (en) | 2004-03-15 | 2004-04-21 | Chiron Srl | Low dose vaccines |
| DK1742659T3 (da) * | 2004-04-05 | 2013-06-03 | Zoetis P Llc | Mikrofluidiserede olie-i-vand-emulsioner og vaccinesammensætninger |
| GB0500787D0 (en) * | 2005-01-14 | 2005-02-23 | Chiron Srl | Integration of meningococcal conjugate vaccination |
| DK1740217T3 (da) * | 2004-04-30 | 2011-09-26 | Novartis Ag | Meningokok-konjugat-vaccination |
| GB0409745D0 (en) * | 2004-04-30 | 2004-06-09 | Chiron Srl | Compositions including unconjugated carrier proteins |
| GB0413868D0 (en) * | 2004-06-21 | 2004-07-21 | Chiron Srl | Dimensional anlaysis of saccharide conjugates |
| MX2007003402A (es) * | 2004-09-22 | 2007-05-10 | Glaxosmithkline Biolog Sa | Composicion inmunogena para su uso en vacunacion contra estafilococos. |
| US20060121055A1 (en) * | 2004-12-06 | 2006-06-08 | Becton, Dickinson And Company, Inc. | Compositions with enhanced immunogenicity |
| GB0428394D0 (en) | 2004-12-24 | 2005-02-02 | Chiron Srl | Saccharide conjugate vaccines |
| GB0502095D0 (en) | 2005-02-01 | 2005-03-09 | Chiron Srl | Conjugation of streptococcal capsular saccharides |
| DK1858920T3 (en) * | 2005-02-18 | 2016-02-29 | Glaxosmithkline Biolog Sa | PROTEINS AND NUCLEIC ACIDS FROM MENINGITIS / SEPSIS-ASSOCIATED ESCHERICHIA COLI |
| GB0505518D0 (en) * | 2005-03-17 | 2005-04-27 | Chiron Srl | Combination vaccines with whole cell pertussis antigen |
| EP2425856A1 (en) | 2005-04-08 | 2012-03-07 | Wyeth LLC | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| US20070184072A1 (en) * | 2005-04-08 | 2007-08-09 | Wyeth | Multivalent pneumococcal polysaccharide-protein conjugate composition |
| EP1885734B1 (en) * | 2005-05-06 | 2015-01-14 | Novartis AG | Immunogens for meningitidis-a vaccines |
| WO2007000341A2 (en) † | 2005-06-27 | 2007-01-04 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
| CN1709505B (zh) | 2005-07-13 | 2010-06-16 | 北京绿竹生物制药有限公司 | 多价细菌荚膜多糖-蛋白质结合物联合疫苗 |
| BRPI0615420A2 (pt) | 2005-09-01 | 2011-05-17 | Novartis Vaccines & Diagnostic | vacinação múltipla que inclui meningococo do sorogrupo c |
| EP2208999B1 (en) * | 2005-09-05 | 2014-08-27 | GlaxoSmithKline Biologicals SA | Serum bactericidal assay for N. meningitidis specific antisera |
| GB0522765D0 (en) * | 2005-11-08 | 2005-12-14 | Chiron Srl | Combination vaccine manufacture |
| HUE032903T2 (hu) * | 2005-12-22 | 2017-11-28 | Glaxosmithkline Biologicals Sa | Streptococcus pneumoniae kapszulárispoliszacharid-konjugátumok |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| AU2006327023A1 (en) | 2005-12-23 | 2007-06-28 | Glaxosmithkline Biologicals Sa | Conjugate vaccines |
| KR20150038626A (ko) * | 2006-03-17 | 2015-04-08 | 더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카 에즈 레프리젠티드 바이 더 세크러테리 오브 더 디파트먼트 오브 헬스 앤드 휴먼 서비시즈 | 복합 다가 면역원성 콘쥬게이트의 제조 방법 |
| PH12013500136A1 (en) * | 2006-03-30 | 2015-03-13 | Glaxosmithkline Biologicals Sa | Immunogenic composition |
| AR060187A1 (es) * | 2006-03-30 | 2008-05-28 | Glaxosmithkline Biolog Sa | Composicion inmunogenica |
| US8039007B2 (en) | 2006-06-29 | 2011-10-18 | J. Craig Venter Institute, Inc. | Polypeptides from Neisseria meningitidis |
| US7491517B2 (en) | 2006-07-19 | 2009-02-17 | Jeeri R Reddy | Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135 |
| WO2008011120A2 (en) | 2006-07-21 | 2008-01-24 | The Regents Of The University Of California | Human endogenous retrovirus polypeptide compositions and methods of use thereof |
| WO2008028957A2 (en) | 2006-09-07 | 2008-03-13 | Glaxosmithkline Biologicals S.A. | Vaccine |
| GB0700136D0 (en) * | 2007-01-04 | 2007-02-14 | Glaxosmithkline Biolog Sa | Process for manufacturing vaccines |
| GB0700135D0 (en) | 2007-01-04 | 2007-02-14 | Glaxosmithkline Biolog Sa | Vaccine |
| JP4858611B2 (ja) | 2007-03-14 | 2012-01-18 | コニカミノルタビジネステクノロジーズ株式会社 | 情報埋め込み方法、そのプログラムおよび情報埋め込み装置 |
| EP2682127A1 (en) | 2007-05-02 | 2014-01-08 | GlaxoSmithKline Biologicals S.A. | Vaccine |
| NZ581367A (en) | 2007-06-04 | 2012-05-25 | Novartis Ag | Formulation of meningitis vaccines containing haemophilus influenzae and neisseria meningitidis |
| CN104873965B (zh) * | 2007-06-26 | 2018-09-11 | 葛兰素史密丝克莱恩生物有限公司 | 包含肺炎链球菌荚膜多糖缀合物的疫苗 |
| GB0714963D0 (en) * | 2007-08-01 | 2007-09-12 | Novartis Ag | Compositions comprising antigens |
| EP2328613A1 (en) | 2008-08-28 | 2011-06-08 | GlaxoSmithKline Biologicals S.A. | Vaccine |
| GB0816447D0 (en) * | 2008-09-08 | 2008-10-15 | Glaxosmithkline Biolog Sa | Vaccine |
| US8259461B2 (en) * | 2008-11-25 | 2012-09-04 | Micron Technology, Inc. | Apparatus for bypassing faulty connections |
| US8974799B2 (en) * | 2009-09-30 | 2015-03-10 | Novartis Ag | Conjugation of Staphylococcus aureus type 5 and type 8 capsular polysaccharides |
| TW201136603A (en) | 2010-02-09 | 2011-11-01 | Merck Sharp & Amp Dohme Corp | 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition |
| GB201003922D0 (en) * | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Conjugation process |
| EP3366696A1 (en) * | 2010-03-11 | 2018-08-29 | GlaxoSmithKline Biologicals S.A. | Vaccine |
| WO2011155196A1 (ja) * | 2010-06-11 | 2011-12-15 | パナソニック株式会社 | 語音聴取の評価システム、その方法およびそのプログラム |
| AU2012335208B2 (en) * | 2011-11-07 | 2017-08-31 | Glaxosmithkline Biologicals S.A. | Carrier molecule comprising a spr0096 and a spr2021 antigen |
| GB2495341B (en) | 2011-11-11 | 2013-09-18 | Novartis Ag | Fermentation methods and their products |
| BR112014018815B1 (pt) * | 2012-01-30 | 2022-07-12 | Serum Institute Of India Ltd. | Composição imunogênica compreendendo conjugado proteína-polissacarídeo x de n. meningitidis |
| SG10201608675YA (en) * | 2012-05-22 | 2016-12-29 | Novartis Ag | Meningococcus serogroup x conjugate |
| WO2014001328A1 (en) | 2012-06-25 | 2014-01-03 | Nadiro A/S | A lifeboat deployment unit |
| PT2928489T (pt) * | 2012-12-05 | 2019-05-28 | Glaxosmithkline Biologicals Sa | Composição imunogénica |
| GB201310008D0 (en) * | 2013-06-05 | 2013-07-17 | Glaxosmithkline Biolog Sa | Immunogenic composition for use in therapy |
| EA201790239A1 (ru) * | 2014-08-05 | 2017-07-31 | Глаксосмитклайн Байолоджикалс С.А. | Молекула-носитель для антигенов |
| TWI715617B (zh) * | 2015-08-24 | 2021-01-11 | 比利時商葛蘭素史密斯克藍生物品公司 | 對抗腸道外病原性大腸桿菌之免疫保護之方法及組合物 |
| GB201518684D0 (en) * | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
| AU2017321863B2 (en) * | 2016-09-02 | 2024-07-11 | Sanofi Pasteur, Inc. | Neisseria meningitidis vaccine |
| US11951165B2 (en) * | 2016-12-30 | 2024-04-09 | Vaxcyte, Inc. | Conjugated vaccine carrier proteins |
| AU2018215585B2 (en) * | 2017-01-31 | 2022-03-17 | Pfizer Inc. | Neisseria meningitidis compositions and methods thereof |
| PE20201443A1 (es) * | 2017-07-18 | 2020-12-10 | Serum Inst Of India Pvt Ltd | Una composicion inmunogenica que tiene estabilidad mejorada, inmunogeneicidad potenciada y reactogenicidad reducida y proceso para la preparacion de la misma |
-
2006
- 2006-06-23 WO PCT/EP2006/006268 patent/WO2007000341A2/en not_active Ceased
- 2006-06-23 US US11/917,709 patent/US9931397B2/en active Active
- 2006-06-23 EA EA200702577A patent/EA013374B1/ru not_active IP Right Cessation
- 2006-06-23 BR BRPI0612670A patent/BRPI0612670B8/pt active IP Right Grant
- 2006-06-23 DK DK06754582.2T patent/DK1896061T3/da active
- 2006-06-23 KR KR1020137028209A patent/KR20130122810A/ko not_active Ceased
- 2006-06-23 SI SI200631109T patent/SI1896065T2/sl unknown
- 2006-06-23 PL PL15189397T patent/PL3009146T3/pl unknown
- 2006-06-23 PT PT101778322T patent/PT2283857T/pt unknown
- 2006-06-23 EP EP06754610A patent/EP1896064A2/en not_active Ceased
- 2006-06-23 HU HUE06754582A patent/HUE045482T2/hu unknown
- 2006-06-23 SI SI200632415T patent/SI3009146T1/sl unknown
- 2006-06-23 CN CN201210028358.6A patent/CN102526723B/zh active Active
- 2006-06-23 CN CN2011101438611A patent/CN102218138A/zh active Pending
- 2006-06-23 EA EA200702576A patent/EA012506B1/ru not_active IP Right Cessation
- 2006-06-23 JP JP2008517440A patent/JP2008543907A/ja active Pending
- 2006-06-23 BR BRPI0612654A patent/BRPI0612654B8/pt active IP Right Grant
- 2006-06-23 WO PCT/EP2006/006220 patent/WO2007000327A1/en not_active Ceased
- 2006-06-23 MX MX2007016403A patent/MX2007016403A/es active IP Right Grant
- 2006-06-23 KR KR1020077031058A patent/KR101351873B1/ko not_active Expired - Fee Related
- 2006-06-23 BR BRPI0612669A patent/BRPI0612669B8/pt active IP Right Grant
- 2006-06-23 ES ES06754599.6T patent/ES2377075T5/es active Active
- 2006-06-23 HU HUE14198052A patent/HUE046905T2/hu unknown
- 2006-06-23 JP JP2008517437A patent/JP5037503B2/ja active Active
- 2006-06-23 DK DK06754611.9T patent/DK1896065T4/da active
- 2006-06-23 PT PT06754611T patent/PT1896065E/pt unknown
- 2006-06-23 WO PCT/EP2006/006270 patent/WO2007000343A2/en not_active Ceased
- 2006-06-23 DE DE602006013313T patent/DE602006013313D1/de active Active
- 2006-06-23 JP JP2008517441A patent/JP5297800B2/ja active Active
- 2006-06-23 EP EP14198052.4A patent/EP2878307B1/en active Active
- 2006-06-23 AR ARP060102725A patent/AR053935A1/es not_active Application Discontinuation
- 2006-06-23 CA CA2611960A patent/CA2611960C/en active Active
- 2006-06-23 CA CA2612980A patent/CA2612980C/en active Active
- 2006-06-23 KR KR1020087002312A patent/KR101408113B1/ko active Active
- 2006-06-23 SI SI200632346T patent/SI1896061T1/sl unknown
- 2006-06-23 SI SI200632159A patent/SI2351578T1/sl unknown
- 2006-06-23 HU HUE10177832A patent/HUE047211T2/hu unknown
- 2006-06-23 PT PT06754582T patent/PT1896061T/pt unknown
- 2006-06-23 NO NO20076343A patent/NO345422B1/no active Protection Beyond IP Right Term
- 2006-06-23 CA CA2611964A patent/CA2611964C/en active Active
- 2006-06-23 MX MX2007016405A patent/MX2007016405A/es active IP Right Grant
- 2006-06-23 PT PT141980524T patent/PT2878307T/pt unknown
- 2006-06-23 HR HRP20110567TT patent/HRP20110567T4/hr unknown
- 2006-06-23 PT PT101798205T patent/PT2351578T/pt unknown
- 2006-06-23 SI SI200631247T patent/SI1896063T1/sl unknown
- 2006-06-23 ES ES10158046.2T patent/ES2662651T3/es active Active
- 2006-06-23 JP JP2008517436A patent/JP5280199B2/ja active Active
- 2006-06-23 PE PE2014001334A patent/PE20142165A1/es active IP Right Grant
- 2006-06-23 NZ NZ564605A patent/NZ564605A/en unknown
- 2006-06-23 AR ARP060102724A patent/AR056397A1/es not_active Application Discontinuation
- 2006-06-23 PL PL06754596T patent/PL1896062T3/pl unknown
- 2006-06-23 US US11/917,726 patent/US8398983B2/en active Active
- 2006-06-23 AT AT06754599T patent/ATE536884T1/de active
- 2006-06-23 EP EP06754611.9A patent/EP1896065B2/en active Active
- 2006-06-23 ES ES06754582T patent/ES2741529T3/es active Active
- 2006-06-23 AR ARP060102723A patent/AR056396A1/es not_active Application Discontinuation
- 2006-06-23 AU AU2006263936A patent/AU2006263936B2/en active Active
- 2006-06-23 BR BRPI0612655-3A patent/BRPI0612655B1/pt active IP Right Grant
- 2006-06-23 PT PT06754599T patent/PT1896063E/pt unknown
- 2006-06-23 DK DK06754596.2T patent/DK1896062T3/da active
- 2006-06-23 WO PCT/EP2006/006210 patent/WO2007000322A1/en not_active Ceased
- 2006-06-23 AU AU2006263965A patent/AU2006263965B2/en active Active
- 2006-06-23 PT PT06754596T patent/PT1896062E/pt unknown
- 2006-06-23 WO PCT/EP2006/006188 patent/WO2007000314A2/en not_active Ceased
- 2006-06-23 AT AT06754611T patent/ATE516816T1/de active
- 2006-06-23 EP EP06754599.6A patent/EP1896063B2/en active Active
- 2006-06-23 AU AU2006263963A patent/AU2006263963B2/en active Active
- 2006-06-23 EP EP15189397.1A patent/EP3009146B1/en active Active
- 2006-06-23 NZ NZ564607A patent/NZ564607A/en unknown
- 2006-06-23 DK DK14198052.4T patent/DK2878307T3/da active
- 2006-06-23 NZ NZ564371A patent/NZ564371A/en not_active IP Right Cessation
- 2006-06-23 KR KR1020077030683A patent/KR101359953B1/ko active Active
- 2006-06-23 PE PE2010000444A patent/PE20110096A1/es active IP Right Grant
- 2006-06-23 MX MX2007016236A patent/MX2007016236A/es active IP Right Grant
- 2006-06-23 PL PL06754599T patent/PL1896063T3/pl unknown
- 2006-06-23 SI SI200632356T patent/SI2283857T1/sl unknown
- 2006-06-23 UA UAA200714086A patent/UA95238C2/uk unknown
- 2006-06-23 US US11/917,569 patent/US8431136B2/en active Active
- 2006-06-23 DK DK10177832T patent/DK2283857T3/da active
- 2006-06-23 PL PL06754611T patent/PL1896065T5/pl unknown
- 2006-06-23 AP AP2007004274A patent/AP2436A/xx active
- 2006-06-23 BR BRPI0612656-1A patent/BRPI0612656B1/pt active IP Right Grant
- 2006-06-23 PE PE2006000719A patent/PE20070163A1/es active IP Right Grant
- 2006-06-23 PT PT151893971T patent/PT3009146T/pt unknown
- 2006-06-23 PL PL06754582T patent/PL1896061T3/pl unknown
- 2006-06-23 ES ES14198052T patent/ES2747025T3/es active Active
- 2006-06-23 ES ES06762248T patent/ES2901378T3/es active Active
- 2006-06-23 ES ES15189397T patent/ES2898451T3/es active Active
- 2006-06-23 SI SI200632352T patent/SI2878307T1/sl unknown
- 2006-06-23 EP EP06762248.0A patent/EP1896066B8/en active Active
- 2006-06-23 KR KR1020137018446A patent/KR101532068B1/ko active Active
- 2006-06-23 JP JP2008517442A patent/JP5731737B2/ja active Active
- 2006-06-23 PE PE2010000450A patent/PE20110072A1/es not_active Application Discontinuation
- 2006-06-23 CN CN201310023297.9A patent/CN103083657B/zh active Active
- 2006-06-23 KR KR1020087002217A patent/KR101351870B1/ko active Active
- 2006-06-23 CA CA2612963A patent/CA2612963C/en active Active
- 2006-06-23 EP EP06754582.2A patent/EP1896061B1/en active Active
- 2006-06-23 ES ES10179820.5T patent/ES2621780T3/es active Active
- 2006-06-23 PE PE2006000720A patent/PE20070499A1/es active IP Right Grant
- 2006-06-23 US US11/917,610 patent/US9789179B2/en active Active
- 2006-06-23 AT AT06754596T patent/ATE462444T1/de active
- 2006-06-23 UA UAA200714084A patent/UA95237C2/uk unknown
- 2006-06-23 DK DK10179820.5T patent/DK2351578T3/en active
- 2006-06-23 EA EA200702574A patent/EA012214B1/ru not_active IP Right Cessation
- 2006-06-23 AU AU2006263944A patent/AU2006263944B2/en active Active
- 2006-06-23 ES ES06754596T patent/ES2340711T3/es active Active
- 2006-06-23 EP EP10158046.2A patent/EP2201961B1/en active Active
- 2006-06-23 KR KR1020077030681A patent/KR101321056B1/ko active Active
- 2006-06-23 HU HUE10179820A patent/HUE031380T2/en unknown
- 2006-06-23 LT LTEP10179820.5T patent/LT2351578T/lt unknown
- 2006-06-23 PL PL10177832T patent/PL2283857T3/pl unknown
- 2006-06-23 EP EP10179820.5A patent/EP2351578B1/en active Active
- 2006-06-23 PL PL10179820T patent/PL2351578T3/pl unknown
- 2006-06-23 HR HR20120102T patent/HRP20120102T1/hr unknown
- 2006-06-23 PL PL14198052T patent/PL2878307T3/pl unknown
- 2006-06-23 EP EP06754596A patent/EP1896062B1/en not_active Revoked
- 2006-06-23 MX MX2007016402A patent/MX2007016402A/es active IP Right Grant
- 2006-06-23 WO PCT/EP2006/006269 patent/WO2007000342A2/en not_active Ceased
- 2006-06-23 EP EP10177832.2A patent/EP2283857B1/en active Active
- 2006-06-23 CA CA2612957A patent/CA2612957C/en active Active
- 2006-06-23 NZ NZ590204A patent/NZ590204A/en unknown
- 2006-06-23 PE PE2006000718A patent/PE20070123A1/es not_active Application Discontinuation
- 2006-06-23 AU AU2006263964A patent/AU2006263964B2/en active Active
- 2006-06-23 DK DK06754599.6T patent/DK1896063T3/da active
- 2006-06-23 EA EA200702575A patent/EA012528B1/ru not_active IP Right Cessation
- 2006-06-23 NZ NZ564370A patent/NZ564370A/en unknown
- 2006-06-23 HU HUE15189397A patent/HUE056842T2/hu unknown
- 2006-06-23 HR HR20100211T patent/HRP20100211T1/hr unknown
- 2006-06-23 MX MX2007016237A patent/MX2007016237A/es active IP Right Grant
- 2006-06-23 US US11/917,702 patent/US9486515B2/en active Active
- 2006-06-23 SI SI200630681T patent/SI1896062T1/sl unknown
- 2006-06-23 US US11/917,580 patent/US8329184B2/en active Active
- 2006-06-23 NZ NZ564606A patent/NZ564606A/en unknown
- 2006-06-23 ES ES10177832T patent/ES2750243T3/es active Active
- 2006-06-26 MY MYPI20063025A patent/MY147490A/en unknown
- 2006-06-26 TW TW102148542A patent/TWI537001B/zh active
- 2006-06-26 TW TW095122969A patent/TWI422386B/zh active
- 2006-06-26 MY MYPI20063023A patent/MY148110A/en unknown
- 2006-06-26 MY MYPI20063024A patent/MY147783A/en unknown
- 2006-06-26 TW TW095122979A patent/TWI407970B/zh active
- 2006-06-26 TW TW095122993A patent/TWI477283B/zh active
- 2006-06-26 TW TW102118476A patent/TW201336507A/zh unknown
-
2007
- 2007-12-06 IL IL187924A patent/IL187924A/en active IP Right Grant
- 2007-12-07 NO NO20076302A patent/NO344452B1/no unknown
- 2007-12-11 NO NO20076350A patent/NO342815B1/no unknown
- 2007-12-11 IL IL188045A patent/IL188045A0/en active IP Right Grant
- 2007-12-11 IL IL188046A patent/IL188046A/en active IP Right Grant
- 2007-12-12 NO NO20076363A patent/NO345305B1/no unknown
- 2007-12-12 IL IL188072A patent/IL188072A/en active IP Right Grant
- 2007-12-26 MA MA30511A patent/MA29602B1/fr unknown
- 2007-12-26 MA MA30512A patent/MA29603B1/fr unknown
- 2007-12-27 MA MA30521A patent/MA29569B1/fr unknown
- 2007-12-27 MA MA30522A patent/MA29993B1/fr unknown
-
2010
- 2010-04-30 CY CY20101100387T patent/CY1109996T1/el unknown
- 2010-07-21 AU AU2010203115A patent/AU2010203115C1/en active Active
- 2010-08-18 AU AU2010212417A patent/AU2010212417A1/en not_active Abandoned
-
2011
- 2011-06-22 IL IL213718A patent/IL213718A/en active IP Right Grant
- 2011-06-28 IL IL213795A patent/IL213795A/en active IP Right Grant
- 2011-08-15 IL IL214657A patent/IL214657A0/en unknown
- 2011-09-15 CY CY20111100883T patent/CY1111827T1/el unknown
-
2012
- 2012-02-21 CY CY20121100175T patent/CY1112698T1/el unknown
- 2012-04-27 US US13/457,891 patent/US8846049B2/en active Active
- 2012-10-11 IL IL222346A patent/IL222346A/en active IP Right Grant
- 2012-10-16 LT LTPA2012019C patent/LTC1896065I2/lt unknown
- 2012-10-16 CY CY2012027C patent/CY2012027I1/el unknown
- 2012-10-18 BE BE2012C042C patent/BE2012C042I2/fr unknown
- 2012-10-19 HU HUS1200023C patent/HUS1200023I1/hu unknown
- 2012-10-19 NL NL300549C patent/NL300549I2/nl unknown
- 2012-10-19 LU LU92085C patent/LU92085I2/fr unknown
- 2012-11-01 JP JP2012241817A patent/JP5769688B2/ja active Active
-
2013
- 2013-02-27 US US13/778,633 patent/US8883163B2/en active Active
- 2013-03-13 JP JP2013050333A patent/JP5718960B2/ja active Active
- 2013-05-14 JP JP2013102249A patent/JP2013209395A/ja active Pending
-
2014
- 2014-10-28 US US14/525,883 patent/US9358279B2/en active Active
-
2015
- 2015-04-28 JP JP2015091394A patent/JP5965512B2/ja active Active
-
2016
- 2016-09-14 US US15/265,597 patent/US10245317B2/en active Active
-
2017
- 2017-02-21 CY CY20171100234T patent/CY1118646T1/el unknown
- 2017-03-20 HR HRP20170457TT patent/HRP20170457T1/hr unknown
- 2017-08-30 US US15/691,440 patent/US10166287B2/en active Active
-
2018
- 2018-11-02 US US16/179,476 patent/US11241495B2/en active Active
-
2019
- 2019-02-05 US US16/268,287 patent/US20200000911A1/en not_active Abandoned
-
2021
- 2021-12-29 LU LU00247C patent/LUC00247I2/fr unknown
-
2022
- 2022-01-13 HU HUS2200002C patent/HUS2200002I1/hu unknown
- 2022-02-21 FR FR22C1008C patent/FR22C1008I2/fr active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008543905A5 (enExample) | ||
| JP2008543908A5 (enExample) | ||
| JP2008543904A5 (enExample) | ||
| JP2008543907A5 (enExample) | ||
| HRP20120102T1 (hr) | Imunogeni pripravak | |
| JP2005508849A5 (enExample) | ||
| DK1296715T4 (en) | Multivalent vaccine composition. | |
| JP2007507578A5 (enExample) | ||
| JP2004501873A5 (enExample) | ||
| EP2172213A3 (en) | Injectable vaccines against multiple meningococcal serogroups | |
| RU2012116119A (ru) | Множественная вакцинация, включающая менингококки серогруппы с | |
| JP2020523323A5 (enExample) | ||
| JP2008526939A5 (enExample) | ||
| CA2442865A1 (en) | Vaccine composition | |
| JP2009525260A5 (enExample) | ||
| JP2005526847A5 (enExample) | ||
| JP2005504718A5 (enExample) | ||
| IL252915B1 (en) | Immunogenic preparations for use in pneumococcal vaccines | |
| JP2010163453A5 (enExample) | ||
| RU2006142156A (ru) | Объединенные менингококковые конъюгаты с общим белком-носителем | |
| RU2007130774A (ru) | Вакцинация менингококковыми конъюгатами | |
| RU2006142158A (ru) | Вакцинация менингококковыми конъюгатами | |
| HK1055244C (en) | Multivalent vaccine composition | |
| HK1055244B (en) | Multivalent vaccine composition | |
| HK1242601B (zh) | 用於肺炎球菌疫苗中的免疫原性组合物 |